CD8A and neoplasm: In this sense, Deauvieau et al. demonstrated that NK cells activated by tumor cells opsonized with IgG1 therapeutic mAbs increased cross-presentation of tumor antigens to CD8+ T lymphocytes by DCs, which was dependent on soluble factors (IFN-γ and TNF-α).